Rocket One Inc., formerly Hoth Therapeutics, Inc., is focused on developing and commercializing infrastructure for the orbital economy, including nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The Company holds exclusive rights to certain technologies, including a nanomagnetic matrix multiplier architecture intended as a hardware accelerator for machine learning and AI workloads, and related magnetic memory technology with potential applications in radiation-tolerant computing for defense and space systems. The Company is also positioned to pursue opportunities in nano-launch systems and nanosatellite deployment. The Company's biotechnology pipeline includes HT-001, HT-KIT, HT-ALZ, and GDNF-based metabolic program.
Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -